| A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer (NCT04718376) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-01-12 |
| Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL (NCT04548700) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-12-24 |
| Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel (NCT04471675) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-12-02 |
| A Study of SYHA1805 in Healthy Adult Subjects (NCT04645901) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-12-01 |
| Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL (NCT04509466) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-09-15 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects (NCT04453618) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-08-01 |
| Study of Desvenlafaxine in Treating Major Depressive Disorder. (NCT04364997) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-06-18 |
| A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy (NCT04352413) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-06-18 |
| A Phase I Trial of Simmitinib in Advanced Solid Tumors (NCT04058587) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-06-08 |
| A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer (NCT04404543) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-06-01 |
| Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors (NCT04060290) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-05-12 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors (NCT04309968) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-04-07 |
| A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM (NCT04218734) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-01-14 |
| A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients (NCT04161430) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-01-02 |
| Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis (NCT04225195) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-01-01 |
| A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma (NCT04707079) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-12-18 |
| Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers (NCT04161547) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-12-12 |
| Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors (NCT04146610) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-11-01 |
| Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran (NCT04197323) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-10-01 |
| Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People (NCT03988413) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-08-05 |
| Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers (NCT04036656) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-08-01 |
| Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects (NCT05173545) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-07-29 |
| A Study of TG103 in Chinese Healthy Adult Subjects (NCT03990090) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-07-29 |
| Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes (NCT03940183) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-07-08 |
| A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (NCT04460820) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-07-04 |
| A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients (NCT04015024) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-07-01 |
| Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours (NCT03852823) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-05-23 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject (NCT03850834) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-03-10 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever (NCT03830684) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-02-01 |
| A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC (NCT03777579) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-12-21 |
| Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets (NCT03994484) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-10-10 |
| A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects (NCT03922373) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-09-10 |
| The Safety and Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers (NCT03669562) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-08-07 |
| Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China (NCT03577509) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-07-02 |
| A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma (NCT03776279) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-04-02 |
| A Study on the Efficacy and Safety of Benzonatate Soft Capsules for Improving Adult Cough Symptoms (NCT03722914) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-03-01 |
| Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer (NCT03262948) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2017-12-01 |
| The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus (NCT03239119) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2017-11-30 |
| Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets (NCT03420534) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2017-11-17 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects (NCT03456388) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2017-10-30 |